FDA warns of caution over use of radiofrequency ablation meter to treat lung tumors
-
Last Update: 2020-07-05
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
the U.SFDA recently warned medical personnel that the use of radiofrequency ablation in lungtumorablation has been reported to cause patient deathsThe patient's death may be related to the patient's choice, follow-up treatment, and the technology used in radiofrequency instruments, including placement and operationAlthough the rfradioagulant's certification was approved for coagulation of soft tissue necrosis through heat, it was not approved for lungtumorablationThe FDA reminds medical personnel to exercise caution when operating RF ablers and to strictly follow the operating instructions, manufacturer's instructions and any operational training requirements
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.